ilomastat has been researched along with Injuries, Radiation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, B; Li, X; Quan, D; Zhang, F; Zhao, B | 1 |
1 other study(ies) available for ilomastat and Injuries, Radiation
| Article | Year |
|---|---|
Ilomastat contributes to the survival of mouse after irradiation via promoting the recovery of hematopoietic system.
Topics: Animals; Gamma Rays; Hematopoietic Stem Cells; Hydroxamic Acids; Indoles; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Oxidative Stress; Radiation Injuries; Reactive Oxygen Species; Spleen; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Whole-Body Irradiation | 2021 |